Sotorasib for previously treated colorectal cancers with KRAS(G12C) mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial - Fakih, MG; Kopetz, S; Kuboki, Y (Lancet Oncol, 2022)
et al.